Wire Stories

Corpay Cross-Border Appoints Roy Farah as new SVP Global Payment Solutions

TORONTO--(BUSINESS WIRE)--Corpay1, a FLEETCOR® (NYSE: FLT) brand and global leader in business payments, is pleased to announce that Corpay’s Cross-Border…

2 years ago

AArete Joins Snowflake Partner Network

Consulting firm’s deep expertise in financial services and healthcare helps clients unlock the full potential of their data through Snowflake…

2 years ago

Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners

2024 Award Celebrates Outstanding Research in Cancer Immunology Winners Discovered Novel Connections Between the Immune System and Cancer Recipients Each…

2 years ago

Saudi Fund for Development Provides $100 Million Development Loan for the Rogun Hydropower Project

SHAHRINAV, Tajikistan--(BUSINESS WIRE)--The Saudi Fund for Development (SFD) Chief Executive Officer, H.E. Sultan Al-Marshad, signed a new development loan agreement…

2 years ago

LTIMindtree Ranks Second in Overall Customer Satisfaction in Whitelane Research’s 2023 IT Sourcing Study for Germany

Achieves a score of 80%, well above the industry average of 74% MUNICH & MUMBAI, India--(BUSINESS WIRE)--$LTIM #ITSourcingStudy--LTIMindtree [NSE: LTIM,…

2 years ago

Transforming Health in Singapore: CueZen Collaborates with Microsoft in the 6th World Blue Zone

SINGAPORE--(BUSINESS WIRE)--CueZen Inc. and Microsoft are collaborating to empower the citizens of Singapore on their journey to optimal health. CueZen’s…

2 years ago

TreviPay Introduces All-in-One Payments Solution for Accepting Net Terms and Card Payments at Checkout

TreviPay continues to expand loyalty-building technology for all merchants to perfect the payments experience OVERLAND PARK, Kan.--(BUSINESS WIRE)--#B2B--TreviPay, the global…

2 years ago

RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)

- Intravitreal umedaptanib pegol (an investigational anti-FGF2 aptamer) is safe, well tolerated, and effective in treatment naïve nAMD patients with…

2 years ago

Netcracker Expands Generative AI Value for the Telecom Industry With Amazon Bedrock

Netcracker Integrates Its GenAI Telco Solution With Amazon Bedrock to Access Multiple Leading Generative AI Models Addressing the Unique Needs…

2 years ago

Options and Systemathics Empower Trading Firms with Next Generation Market Data Solution

LONDON & NEW YORK & HONG KONG--(BUSINESS WIRE)--Options Technology, the leading Capital Markets services provider today announced a new partnership…

2 years ago